These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2494178)

  • 41. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation.
    Dhoest A; Zhao Z; De Geest B; Deridder E; Sillen A; Engelborghs Y; Collen D; Holvoet P
    J Biol Chem; 1997 Jun; 272(25):15967-72. PubMed ID: 9188498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer.
    Calabresi L; Franceschini G; Burkybile A; Jonas A
    Biochem Biophys Res Commun; 1997 Mar; 232(2):345-9. PubMed ID: 9125178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cholesterol on the charge and structure of apolipoprotein A-I in recombinant high density lipoprotein particles.
    Sparks DL; Davidson WS; Lund-Katz S; Phillips MC
    J Biol Chem; 1993 Nov; 268(31):23250-7. PubMed ID: 8226847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
    J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human apolipoprotein A-I liberated from high-density lipoprotein without denaturation.
    Ryan RO; Yokoyama S; Liu H; Czarnecka H; Oikawa K; Kay CM
    Biochemistry; 1992 May; 31(18):4509-14. PubMed ID: 1581305
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.
    Gauthamadasa K; Vaitinadin NS; Dressman JL; Macha S; Homan R; Greis KD; Silva RA
    J Biol Chem; 2012 Mar; 287(10):7615-25. PubMed ID: 22235130
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
    Nichols AV; Blanche PJ; Shore VG; Gong EL
    Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice.
    Chroni A; Kan HY; Kypreos KE; Gorshkova IN; Shkodrani A; Zannis VI
    Biochemistry; 2004 Aug; 43(32):10442-57. PubMed ID: 15301543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method.
    Li Z; McNamara JR; Ordovas JM; Schaefer EJ
    J Lipid Res; 1994 Sep; 35(9):1698-711. PubMed ID: 7806982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function.
    Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP
    J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical and chemical characteristics of apolipoprotein A-I-lipid complexes produced by Chinese hamster ovary cells transfected with the human apolipoprotein A-I gene.
    Forte TM; McCall MR; Amacher S; Nordhausen RW; Vigne JL; Mallory JB
    Biochim Biophys Acta; 1990 Oct; 1047(1):11-8. PubMed ID: 2123400
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular pathways in the transformation of model discoidal lipoprotein complexes induced by lecithin:cholesterol acyltransferase.
    Nichols AV; Blanche PJ; Gong EL; Shore VG; Forte TM
    Biochim Biophys Acta; 1985 May; 834(3):285-300. PubMed ID: 3995066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structural and functional properties of apolipoprotein A-I mutants containing disulfide-linked cysteines at positions 124 or 232.
    Tian S; Jonas A
    Biochim Biophys Acta; 2002 Sep; 1599(1-2):56-64. PubMed ID: 12479405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein A-I structural modification and the functionality of reconstituted high density lipoprotein particles in cellular cholesterol efflux.
    Gillotte KL; Davidson WS; Lund-Katz S; Rothblat GH; Phillips MC
    J Biol Chem; 1996 Sep; 271(39):23792-8. PubMed ID: 8798607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid transfer particle-induced transformation of human high density lipoprotein into apolipoprotein A-I-deficient low density particles.
    Silver ET; Scraba DG; Ryan RO
    J Biol Chem; 1990 Dec; 265(36):22487-92. PubMed ID: 2125050
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
    Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
    J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
    Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
    Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.